Author: Kate Gallin Heffernan, Marylana Saadeh Helou and Robert Romanchuk

Kate Gallin Heffernan, Partner at Verrill Dana, LLP; Marylana Saadeh Helou, Associate at Verrill Dana, LLP; and Robert Romanchuk, IRB Chair at Advarra, provide an overview of the current state of the FDA’s Expanded Access Program and state and federal “Right to Try” legislative efforts.

Download Webinar Slides

Back to Resources